Target type: biologicalprocess
Any process in which a symbiont stops, prevents, or reduces the frequency, rate or extent of defense-related programmed cell death in the host organism. The host is defined as the larger of the organisms involved in a symbiotic interaction. [GOC:pamgo_curators]
Symbiont-mediated suppression of host defense-related programmed cell death is a fascinating and complex process where a symbiotic organism manipulates its host's cellular machinery to evade immune responses and promote its own survival. This intricate interaction often involves the hijacking of host signaling pathways that regulate programmed cell death (PCD), a crucial defense mechanism against pathogens and harmful stimuli.
Here's a detailed breakdown of the process:
1. **Host Immune Recognition:** Upon encountering a pathogen or other threat, the host immune system mounts a response involving the activation of innate and adaptive immune cells. This response often culminates in PCD of infected or damaged cells, preventing the spread of the infection.
2. **Symbiont Interference:** Symbiotic organisms, in contrast to pathogens, aim to establish a long-term, mutually beneficial relationship with their host. To achieve this, they need to circumvent the host's defense mechanisms, including PCD. Symbionts employ a variety of strategies to suppress host PCD, such as:
* **Modulation of Host Signaling Pathways:** Symbionts often secrete effector molecules that interfere with host signaling pathways involved in PCD. These molecules can mimic or antagonize host signaling proteins, disrupting the activation of caspases, the key executioners of PCD. For instance, some symbionts produce proteins that directly inhibit the activity of pro-apoptotic caspases.
* **Induction of Anti-Apoptotic Genes:** Symbionts can manipulate host gene expression to favor the production of anti-apoptotic proteins. These proteins counteract the pro-apoptotic signals, effectively blocking the execution of PCD.
* **Suppression of Immune Cell Activity:** Symbionts can suppress the activity of immune cells involved in the induction of PCD. This can be achieved through the production of immunomodulatory molecules that dampen the inflammatory response and prevent the activation of immune effector cells.
3. **Maintaining Symbiosis:** By effectively suppressing host PCD, symbionts create a favorable environment for their own survival and proliferation within the host. This suppression allows the symbiont to establish a long-term association with the host, benefiting both organisms through nutrient exchange, protection from environmental stressors, or other mutualistic interactions.
Overall, symbiont-mediated suppression of host defense-related PCD is a delicate balance between the host's need to maintain its integrity and the symbiont's need to evade the host's defense system. This intricate interplay of molecular mechanisms showcases the remarkable adaptability of both symbiotic partners and highlights the complexity of host-microbe interactions.'
"
Protein | Definition | Taxonomy |
---|---|---|
N-acetyltransferase Eis | [no definition available] | Mycobacterium tuberculosis H37Rv |
Compound | Definition | Classes | Roles |
---|---|---|---|
bromperidol | bromperidol: bromine-substituted for chlorine in haloperidol; RN given refers to unlabeled parent cpd; structure | aromatic ketone | |
droperidol | droperidol : An organofluorine compound that is haloperidol in which the hydroxy group has been eliminated with the introduction of a double bond in the piperidine ring, and the 4-chlorophenyl group has been replaced by a benzimidazol-2-on-1-yl group. It is used in the management of chemotherapy-induced nausea and vomiting, and in conjunction with an opioid analgesic such as fentanyl to maintain the patient in a calm state of neuroleptanalgesia with indifference to surroundings but still able to cooperate with the surgeon. Droperidol: A butyrophenone with general properties similar to those of HALOPERIDOL. It is used in conjunction with an opioid analgesic such as FENTANYL to maintain the patient in a calm state of neuroleptanalgesia with indifference to surroundings but still able to cooperate with the surgeon. It is also used as a premedicant, as an antiemetic, and for the control of agitation in acute psychoses. (From Martindale, The Extra Pharmacopoeia, 29th ed, p593) | aromatic ketone; benzimidazoles; organofluorine compound | anaesthesia adjuvant; antiemetic; dopaminergic antagonist; first generation antipsychotic |
haloperidol | haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety. Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) | aromatic ketone; hydroxypiperidine; monochlorobenzenes; organofluorine compound; tertiary alcohol | antidyskinesia agent; antiemetic; dopaminergic antagonist; first generation antipsychotic; serotonergic antagonist |
4(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine | 4(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine: metabolite of haloperidol; much less potent neuroleptic agent than haloperidol; structure in first source | aromatic ketone | |
1-(3-(4-chlorobenzoyl)propyl)-4-hydroxy-4-(4-chlorophenyl)piperidine | 1-(3-(4-chlorobenzoyl)propyl)-4-hydroxy-4-(4-chlorophenyl)piperidine: RN given refers to parent cpd |